[logo] HealthTree Foundation
search person

What Is Acute Lymphocytic Leukemia?

What is Acute Lymphocytic Leukemia (ALL)?

Acute lymphocytic leukemia (ALL), also called acute lymphoblastic leukemia or acute lymphoid leukemia, is a cancer that starts in the early forms of white blood cells in the bone marrow—the soft tissue inside bones. The term "acute" refers to the rapid progression of the disease, which can become life-threatening within weeks or months if not treated. "Lymphocytic" indicates that the cancer affects lymphocytes, a type of white blood cell.

The Role of Lymphocytes in ALL 

Lymphocytes are a crucial part of the immune system, responsible for defending the body against infections. These cells are produced in the bone marrow, where they mature before entering the bloodstream and lymphatic system. In ALL, immature lymphocytes, known as lymphoblasts or leukemic blasts, multiply uncontrollably. These cancerous cells crowd out healthy blood cells and eventually spill into the bloodstream, impairing the immune system's ability to fight infections. Additionally, these cells may invade other organs, leading to various symptoms.

Who Gets Acute Lymphocytic Leukemia?

ALL is the most common type of childhood cancer, with the highest incidence occurring in children aged 2 to 5. However, it can also affect adults, though it is less common in people over 40. Key statistics include:

  • New Cases (2023): An estimated 6,540 new cases of ALL in the U.S. (0.3% of all new cancer diagnoses).
  • Prevalence (2020): Approximately 111,425 people were living with ALL in the U.S.

ALL is slightly more common in males than females, and it is more prevalent in Caucasians compared to African Americans or Asian Americans.

What Causes Acute Lymphocytic Leukemia?

The exact cause of ALL is not fully understood, but several factors may increase the risk of developing the disease:

  • Radiation Exposure: High exposure to ionizing radiation (e.g., from radiation therapy or nuclear accidents) may raise the risk of ALL.
  • Genetic Disorders: Conditions like Down syndrome, Li-Fraumeni syndrome, and neurofibromatosis type 1 can increase the risk of ALL.
  • Blood Disorders: Individuals with blood disorders such as myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs) may have a higher risk.
  • Family History: A family history of leukemia can slightly increase the risk, though most cases are not inherited.
  • Chemical Exposure: Some studies suggest links between exposure to chemicals like benzene and pesticides and an increased risk of ALL, though evidence is unclear.
  • Gender and Age: ALL is more common in children and slightly more common in males. The risk decreases with age and is rare in adults.

It's important to note that many people who develop ALL have no known risk factors.

If you or a loved one has been diagnosed with Acute Lymphocytic Leukemia, explore treatment options and connect with a specialist to discuss your personalized care plan.

ALL Specialist Directory
 

What is Acute Lymphocytic Leukemia (ALL)?

Acute lymphocytic leukemia (ALL), also called acute lymphoblastic leukemia or acute lymphoid leukemia, is a cancer that starts in the early forms of white blood cells in the bone marrow—the soft tissue inside bones. The term "acute" refers to the rapid progression of the disease, which can become life-threatening within weeks or months if not treated. "Lymphocytic" indicates that the cancer affects lymphocytes, a type of white blood cell.

The Role of Lymphocytes in ALL 

Lymphocytes are a crucial part of the immune system, responsible for defending the body against infections. These cells are produced in the bone marrow, where they mature before entering the bloodstream and lymphatic system. In ALL, immature lymphocytes, known as lymphoblasts or leukemic blasts, multiply uncontrollably. These cancerous cells crowd out healthy blood cells and eventually spill into the bloodstream, impairing the immune system's ability to fight infections. Additionally, these cells may invade other organs, leading to various symptoms.

Who Gets Acute Lymphocytic Leukemia?

ALL is the most common type of childhood cancer, with the highest incidence occurring in children aged 2 to 5. However, it can also affect adults, though it is less common in people over 40. Key statistics include:

  • New Cases (2023): An estimated 6,540 new cases of ALL in the U.S. (0.3% of all new cancer diagnoses).
  • Prevalence (2020): Approximately 111,425 people were living with ALL in the U.S.

ALL is slightly more common in males than females, and it is more prevalent in Caucasians compared to African Americans or Asian Americans.

What Causes Acute Lymphocytic Leukemia?

The exact cause of ALL is not fully understood, but several factors may increase the risk of developing the disease:

  • Radiation Exposure: High exposure to ionizing radiation (e.g., from radiation therapy or nuclear accidents) may raise the risk of ALL.
  • Genetic Disorders: Conditions like Down syndrome, Li-Fraumeni syndrome, and neurofibromatosis type 1 can increase the risk of ALL.
  • Blood Disorders: Individuals with blood disorders such as myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs) may have a higher risk.
  • Family History: A family history of leukemia can slightly increase the risk, though most cases are not inherited.
  • Chemical Exposure: Some studies suggest links between exposure to chemicals like benzene and pesticides and an increased risk of ALL, though evidence is unclear.
  • Gender and Age: ALL is more common in children and slightly more common in males. The risk decreases with age and is rare in adults.

It's important to note that many people who develop ALL have no known risk factors.

If you or a loved one has been diagnosed with Acute Lymphocytic Leukemia, explore treatment options and connect with a specialist to discuss your personalized care plan.

ALL Specialist Directory
 

newsletter icon

Get the latest thought leadership on your Acute Lymphocytic Leukemia delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.